Accessibility Menu

Sinopharm Group(FRA) X2S

Market Cap€5.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€1.72
-0.64%
-0.01Today

Sinopharm Group Financials at a Glance

Market Cap

€5.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€0.28

P/E Ratio

6.17

Dividend

€0.09

Beta (Volatility)

-0.06 (Low)

Price

€1.72

Volume

10,297

Open

€1.71

Previous Close

€1.72

Daily Range

€1.71 - €1.72

52-Week Range

€1.69 - €2.37

Estimated Earnings Date

N/A

X2S News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sinopharm Group

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

94,910

Website

ir.sinopharmgroup.com.cn

X2S Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

8.47%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

16.21%

Dividend Yield

5.15%

Payout Ratio

N/A

Stock Overview

Market Cap

€5.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.12B

Volume

10.30K

Avg. Volume

1.15K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Sinopharm Group Performance Analysis

Sinopharm Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 78,020,437,75714.1%
20232023-12-31EUR 77,883,839,014-0.2%
20242024-12-31EUR 75,083,895,277-3.6%
20252025-12-31EUR 70,897,010,461-5.6%
Sinopharm Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.3918.4%
20232023-12-31EUR 0.38-1.9%
20242024-12-31EUR 0.29-23.4%
20252025-12-31EUR 0.28-2.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€5.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About X2S

What is the current price of Sinopharm Group?

Sinopharm Group is trading at €1.72 per share.

What is the 52-week range for Sinopharm Group?

Over the past 52 weeks, Sinopharm Group has traded between €1.69 and €2.37.

How much debt does Sinopharm Group have?

As of the most recent reporting period, Sinopharm Group reported total debt of €12.22B.

How much cash does Sinopharm Group have on hand?

Sinopharm Group reported €7.18B in cash and cash equivalents in its most recent financial results.

What is Sinopharm Group’s dividend yield?

Sinopharm Group currently has a dividend yield of 5.15%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services